{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T15:36:42Z","timestamp":1762270602051,"version":"build-2065373602"},"reference-count":66,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.ghir.2004.04.001","type":"journal-article","created":{"date-parts":[[2004,5,13]],"date-time":"2004-05-13T07:02:56Z","timestamp":1084431776000},"page":"301-308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Therapeutic applications of the insulin-like growth factors"],"prefix":"10.1016","volume":"14","author":[{"given":"Martin O","family":"Savage","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Camacho-H\u00fcbner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David B","family":"Dunger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2004.04.001_BIB1","series-title":"IGF in Health and Disease","first-page":"651","article-title":"IGF-deficiency","author":"Woods","year":"2000"},{"key":"10.1016\/j.ghir.2004.04.001_BIB2","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJM199610313351805","article-title":"Intrauterine growth retardation and post-natal growth failure associated with deletion of the insulin-like growth factor-I gene","volume":"355","author":"Woods","year":"1996","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ghir.2004.04.001_BIB3","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1210\/jcem.84.5.5649","article-title":"Effects of recombinant human insulin-like growth factor-I (IGF-I) therapy on the growth hormone-IGF system of a patient with partial IGF-I gene deletion","volume":"84","author":"Camacho-H\u00fcbner","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.04.001_BIB4","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1210\/jcem.85.4.6495","article-title":"Effects of insulin-like growth factor I (IGF-I) therapy on body composition and insulin resistance in IGF-I gene deletion","volume":"85","author":"Woods","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.04.001_BIB5","first-page":"P2","article-title":"Clinical and biochemical expression of a homozygous missense mutation in the IGF-1 gene","author":"Pereira Arias","year":"2003","journal-title":"Endocrine Soc."},{"key":"10.1016\/j.ghir.2004.04.001_BIB6","first-page":"1465","article-title":"Clinical and endocrine status in patients with growth hormone insensitivity (Laron syndrome)","volume":"77","author":"Savage","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.04.001_BIB7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1210\/edrv-15-3-369","article-title":"Growth hormone (GH) insensitivity due to primary GH receptor deficiency","volume":"15","author":"Rosenfeld","year":"1994","journal-title":"Endoc. Rev."},{"key":"10.1016\/j.ghir.2004.04.001_BIB8","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1056\/NEJM199011153232002","article-title":"The little women of Loja \u2013 growth hormone receptor deficiency in an inbred population of Southern Ecuador","volume":"323","author":"Rosenbloom","year":"1990","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ghir.2004.04.001_BIB9","first-page":"3529","article-title":"Phenotype: genotype relationships in growth hormone insensitivity syndrome","volume":"82","author":"Woods","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.04.001_BIB10","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1056\/NEJMoa022926","article-title":"Growth hormone insensitivity associated with a STAT5b mutation","volume":"349","author":"Kofoed","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ghir.2004.04.001_BIB11","first-page":"125","article-title":"Clinical and endocrine characteristics in atypical and classical growth hormone insensitivity syndrome","volume":"55","author":"Burren","year":"2001","journal-title":"Horm. Res."},{"key":"10.1016\/j.ghir.2004.04.001_BIB12","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1365-2265.2002.01607.x","article-title":"Spontaneous growth hormone secretory characteristics in children with partial growth hormone insensitivity","volume":"57","author":"Bjarnason","year":"2002","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2004.04.001_BIB13","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/adc.68.6.768","article-title":"Growth curves for Laron syndrome","volume":"68","author":"Laron","year":"1993","journal-title":"Arch. Dis. Child"},{"key":"10.1016\/j.ghir.2004.04.001_BIB14","series-title":"IGF in Health and Disease","first-page":"739","article-title":"IGF-I treatment of growth hormone insensitivity","author":"Rosenbloom","year":"2000"},{"key":"10.1016\/j.ghir.2004.04.001_BIB15","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/S0140-6736(88)90236-X","article-title":"Effect of acute administration of insulin-like growth factor I in patients with Laron-type dwarfism","volume":"ii","author":"Laron","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2004.04.001_BIB16","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJM199105233242107","article-title":"Effects of the infusion of insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron dwarfism)","volume":"324","author":"Walker","year":"1991","journal-title":"N. Engl. J. Med."},{"issue":"Suppl.","key":"10.1016\/j.ghir.2004.04.001_BIB17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1651-2227.1993.tb12918.x","article-title":"Pharmacokinetcis of recombinant human insulin-like growth factor I given subcutaneously to healthy volunteers and to patients with growth hormone receptor deficiency","volume":"391","author":"Grahnen","year":"1993","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ghir.2004.04.001_BIB18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2265.1993.tb01761.x","article-title":"The effect of recombinant human insulin-like growth factor-I treatment on growth hormone secretion in two subjects with growth hormone insensitivity (Laron syndrome)","volume":"39","author":"Cotterill","year":"1993","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2004.04.001_BIB19","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/0140-6736(92)91594-X","article-title":"Effects of insulin-like growth factor on linear growth, head circulmference and body fat in patients with Laron-type dwarfism","volume":"339","author":"Laron","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2004.04.001_BIB20","first-page":"1393","article-title":"A randomized, double-blind, placebo controlled trial on safety and efficacy of recombinant human insulin-like growth factor-I in children with growth hormone receptor deficiency","volume":"80","author":"Guevara-Aguirre","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.04.001_BIB21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000184637","article-title":"Insulin-like growth factor (IGF)-I improves height in growth hormone insensitivity. Two year's results","volume":"44","author":"Ranke","year":"1995","journal-title":"Horm. Res."},{"key":"10.1016\/j.ghir.2004.04.001_BIB22","first-page":"3312","article-title":"The GHIS collaborative group. Prolonged treatment with recombinant insulin-like growth factor-I in children with growth hormone insensitivity syndrome \u2013 a clinical research center study","volume":"81","author":"Backeljauw","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.04.001_BIB23","first-page":"128","article-title":"Treatment of growth hormone insensitivity syndrome with insulin-like growth factor-I: long-term results of the European multicentre study","volume":"51","author":"Ranke","year":"1999","journal-title":"Horm. Res."},{"key":"10.1016\/j.ghir.2004.04.001_BIB24","first-page":"1504","article-title":"The GHIS collaborative group. Therapy for 6.5\u20137.5 years with recombinant insulin-like growth factor I in children with growth hormone insensitivity syndrome: a clinical research center study","volume":"86","author":"Backeljauw","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.04.001_BIB25","first-page":"629","article-title":"Two year treatment of growth hormone receptor deficiency (GHRD) with recombinant insulin-like growth factor \u2013 I in 22 children: comparison of two dosage levels and to GH treated GH deficiency","volume":"82","author":"Guevara-Aguirre","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.ghir.2004.04.001_BIB26","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0950-351X(96)80530-1","article-title":"Treatment of growth hormone insensitivity syndrome (GHIS) with insulin-like growth factor (IGF-I)","volume":"10","author":"Ranke","year":"1996","journal-title":"Bailliere's Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.04.001_BIB27","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1046\/j.1365-2265.1999.00887.x","article-title":"Growth response to rhIGF-I 80 \u03bcg\/kg twice daily in children with growth hormone insensitivity syndrome: relationship to severity of clinical phenotype","volume":"51","author":"Azcona","year":"1999","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2004.04.001_BIB28","series-title":"IGF in Health and Disease","first-page":"721","article-title":"IGF in the treatment of diabetes","author":"Gabbay","year":"2000"},{"key":"10.1016\/j.ghir.2004.04.001_BIB29","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1365-2265.1994.tb02584.x","article-title":"Loss of the normal relationships between growth hormone, growth hormone-binding protein and insulin-like growth factor-I in adolescents with insulin-dependent diabetes mellitus","volume":"41","author":"Clayton","year":"1994","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2004.04.001_BIB30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0168-8227(94)90155-4","article-title":"Insulin-like growth factors and binding proteins in patients with recent onset type I diabetes mellitus: influence of diabetes control and intraportal insulin infusion","volume":"25","author":"Shishko","year":"1995","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.ghir.2004.04.001_BIB31","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1464-5491.1995.tb00391.x","article-title":"The effects of repeated daily recombinant human insulin-like growth factor I administration in adolescents with type I diabetes","volume":"12","author":"Cheetham","year":"1995","journal-title":"Diabetic Med."},{"key":"10.1016\/j.ghir.2004.04.001_BIB32","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(97)06467-2","article-title":"Randomised placebo-controlled trial of human recombinant insulin-like growth factor plus intensive insulin therapy in adolescents with insulin-dependent diabetes mellitus","volume":"350","author":"Acerini","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2004.04.001_BIB33","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2337\/diabetes.49.5.789","article-title":"IGF-I treatment in adults with type I diabetes. Effects on glucose and protein metabolism in the fasting state and during a hyperinsulinemic-euglycemic amino acid clamp","volume":"49","author":"Carroll","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.ghir.2004.04.001_BIB34","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1210\/jc.2003-031274","article-title":"Insulin-like growth factor I has a direct effect on glucose and protein metabolism, but no effect on lipid metabolism in type 1 diabetes","volume":"89","author":"Simpson","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.04.001_BIB35","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1210\/jcem.86.8.7722","article-title":"The role of IGF-binding proteins in mediating the effects of recombinant human IGF-I on insulin requirements in type 1 diabetes mellitus","volume":"86","author":"Crowne","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.04.001_BIB36","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1172\/JCI116109","article-title":"Insulin-growth factor-I improves glucose and lipid metabolism in type 2 diabetes mellitus","volume":"90","author":"Zenobi","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ghir.2004.04.001_BIB37","first-page":"1563","article-title":"Short-term effects of recombinant human insulin-like growth factor-I of metabolic control of patients with type II diabetes","volume":"77","author":"Schalch","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.04.001_BIB38","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2337\/diab.43.3.369","article-title":"Adverse effects of recombinant human insulin-like growth factor I in obese insulin-resistant type II diabetic patients","volume":"53","author":"Jabri","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/j.ghir.2004.04.001_BIB39","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2337\/diab.45.1.91","article-title":"Recombinant human insulin-like growth factor-I increases insulin sensitivity and improves glycemic control in type II diabetes","volume":"45","author":"Moses","year":"1996","journal-title":"Diabetes"},{"issue":"Suppl. 1","key":"10.1016\/j.ghir.2004.04.001_BIB40","first-page":"1484","article-title":"Zysow B for the RINDS and RICS groups. RhIGF-I improves coronary risk factors in type II diabetes (abstract)","volume":"40","author":"Moses","year":"1997","journal-title":"Diabetologia"},{"issue":"9","key":"10.1016\/j.ghir.2004.04.001_BIB41","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1210\/jcem.83.9.5143","article-title":"Clinical review 97: syndromes of severe insulin resistance","volume":"83","author":"Tritos","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.04.001_BIB42","doi-asserted-by":"crossref","first-page":"696","DOI":"10.2337\/diab.42.5.696","article-title":"Trial of insulin like growth factor I therapy for patient with extreme insulin resistance syndromes","volume":"42","author":"Kuzuya","year":"1993","journal-title":"Diabetes"},{"issue":"20","key":"10.1016\/j.ghir.2004.04.001_BIB43","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJM199011153232016","article-title":"Acute response to recombinant insulin-like growth factor I in a patient with Mendenhalll's syndrome","volume":"323","author":"Quin","year":"1990","journal-title":"New Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ghir.2004.04.001_BIB44","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1210\/jcem.83.2.4602","article-title":"Long-term effect of recombinant human insulin like growth factor I on metabolic and growth control in patient with leprechaunism","volume":"83","author":"Nakae","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.04.001_BIB45","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S1043-2760(02)00631-8","article-title":"Investigation of the growth hormone \u2013 IGF-I axis in idiopathic short stature","volume":"13","author":"Blair","year":"2002","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.04.001_BIB46","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJM199510263331701","article-title":"Mutations of the growth hormone receptor in children with idiopathic short stature","volume":"333","author":"Goddard","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ghir.2004.04.001_BIB47","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/S0022-3476(97)70012-X","article-title":"Partial growth hormone insensitivity: the role of growth hormone receptor mutations in idiopathic short stature","volume":"131","author":"Goddard","year":"1997","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ghir.2004.04.001_BIB48","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/ng0597-13","article-title":"A dominant-negative mutation of the growth hormone receptor causes familial short stature","volume":"16","author":"Ayling","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ghir.2004.04.001_BIB49","first-page":"531","article-title":"Growth hormone (GH) insensitivity syndrome with high serum GH-binding protein levels caused by a heterozygous splice site mutation of the GH receptor gene producing a lack of intracellular domain","volume":"83","author":"Iida","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.04.001_BIB50","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0022-3476(95)70302-0","article-title":"Evidence for partial growth hormone insensitivity among patients with idiopathic short sature. The national cooperative growth study","volume":"127","author":"Attie","year":"1995","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ghir.2004.04.001_BIB51","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1365-2265.2003.01701.x","volume":"58","author":"Rogol","year":"2003","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2004.04.001_BIB52","first-page":"237","article-title":"Reproducibility in patterns of IGF generation with special reference to idiopathic short stature","volume":"60","author":"Selva","year":"2003","journal-title":"Horm. Res."},{"key":"10.1016\/j.ghir.2004.04.001_BIB53","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1210\/jcem.86.9.7850","article-title":"Study of GH sensitivity in Chilean patients with idiopathic short stature","volume":"86","author":"Sjoberg","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.04.001_BIB54","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-2265.2004.01957.x","article-title":"Standard and low dose IGF-I generation tests and spontaneous growth hormone secretion in children with idiopathic short stature","volume":"60","author":"Blair","year":"2004","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2004.04.001_BIB55","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1530\/eje.0.1460319","article-title":"Can exaggerated response to a provocative test identify patients with partial GH insensitivity syndrome?","volume":"146","author":"Rakover","year":"2002","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2004.04.001_BIB56","doi-asserted-by":"crossref","unstructured":"C.E. Brain, M.O. Savage, Disturbance of growth and pubertal development in chronic inflammatory bowel disease, in: J.A. Walker-Smith, T.T. MacDonald (Eds.), Chronic Inflammatory Bowel Disease in Childhood, Bailli\u00e8re's Clin. Gastroenterol. (1994) 83\u2013100","DOI":"10.1016\/S0950-3528(06)80020-5"},{"key":"10.1016\/j.ghir.2004.04.001_BIB57","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1046\/j.1365-2265.1998.00562.x","article-title":"Responsiveness of IGF-I and IGFBP-3 to therapeutic intervention in children and adolescents with Crohn's disease","volume":"48","author":"Beattie","year":"1998","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2004.04.001_BIB58","first-page":"159","article-title":"Relationships between serum IGF-I, IGFBP-2, Iinterleukin-1beta and interleukin-6 in inflammatory bowel disease","volume":"61","author":"Street","year":"2004","journal-title":"Horm. Res."},{"issue":"4","key":"10.1016\/j.ghir.2004.04.001_BIB59","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1172\/JCI119207","article-title":"Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation","volume":"99","author":"De Benedetti","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ghir.2004.04.001_BIB60","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/art.1780400218","article-title":"Effects of disease activity and recombinant human growth hormone on insulin-like growth factor 1, insulin-like growth factor binding proteins 1 and 3, and osteocalcin","volume":"40","author":"Davies","year":"1997","journal-title":"Arthrit. Rheum."},{"issue":"1","key":"10.1016\/j.ghir.2004.04.001_BIB61","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00003246-200201000-00043","article-title":"Modulation of types I and II acute phase reactants with insulin-like growth factor-I\/binding protein 3 complex in serverely burned children","volume":"30","author":"Levetown","year":"2002","journal-title":"Crit. Care Med."},{"issue":"4","key":"10.1016\/j.ghir.2004.04.001_BIB62","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1210\/jcem.87.4.8426","article-title":"Muskuloskeletal effects of the recombinant human IGF-I\/IGF binding protein-3 complex in osteoporotic patients with proximal femoral fracture: a double blind, placebo-controlled pilot study","volume":"87","author":"Boonen","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.ghir.2004.04.001_BIB63","first-page":"1518","article-title":"The combination of insulin-like growth factor I and insulin-like growth factor binding protein-3 reduces insulin requirements in insulin-dependent type I diabetes: evidence for in vivo biological activity","volume":"85","author":"Clemmons","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.04.001_BIB64","unstructured":"A.D. Rogol, W. Jacobson, A. Smith, et al., A double-blind, randomized, placebo-controlled, study to determine the dose response profile of rhIGF-I\/rhIGFBP-3 in subjects with Type 2 Diabetes Mellitus requiring insulin therapy, Poster American Diabetes Association 61st Scientific Sessions, June, San Francisco, 2002"},{"issue":"Suppl. 2","key":"10.1016\/j.ghir.2004.04.001_BIB65","first-page":"1","article-title":"Effects of Combined recombinant human insulin-like growth factor-I\/insulin-like growth factor binding protein 3 on growth hormone secretion and insulin sensitivity in adolescent with type I diabetes","volume":"60","author":"Saukkoman","year":"2003","journal-title":"Horm. Res."},{"issue":"Suppl. 2","key":"10.1016\/j.ghir.2004.04.001_BIB66","first-page":"1","article-title":"Recombinant human insulin-like growth factor (IGF)-I\/IGF binding protein-3 complex administered to patients with growth hormone insensitivity syndrome","volume":"60","author":"Camacho-H\u00fcbner","year":"2003","journal-title":"Horm. Res."}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637404000735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637404000735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:40:22Z","timestamp":1761086422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637404000735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S1096637404000735"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2004.04.001","relation":{},"ISSN":["1096-6374"],"issn-type":[{"type":"print","value":"1096-6374"}],"subject":[],"published":{"date-parts":[[2004,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic applications of the insulin-like growth factors","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2004.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}